Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

599.74 +2.82 (+0.47%)
Streaming Delayed Price Updated: 1:41 PM EDT, Oct 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Crude Oil Edges Higher; Thermo Fisher Scientific Cuts FY23 Forecast
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 150 points on Wednesday. The Dow traded up 0.20% to 33,206.51 while the NASDAQ fell 1.76% to... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Thermo Fisher Slumps After Medical Behemoth Cuts Its 2023 Outlook — Again
The company beat earnings expectations, but sales came in light. 
Via Investor's Business Daily
Earnings Scheduled For October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity For October 19
Via Benzinga
Visa To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
What 11 Analyst Ratings Have To Say About Thermo Fisher Scientific
Via Benzinga
Why Olink Stock Is Skyrocketing Today
Investors are cheering a huge acquisition offer from Thermo Fisher. 
Via The Motley Fool
Investor Risk Sentiment Wavers Amid War, Interest Rate Concerns; Tesla Earnings Disappoint: The Week In The Markets
In the week ahead, earnings season moves into full swing with reports from companies like Microsoft, Alphabet, Meta Platforms and Amazon. 
Via Benzinga
Why Proteomics Solutions Provider Olink's Shares Are Rocketing Today
Olink Holding AB (NASDAQ: OLK) shares are trading higher by over 65% after Thermo Fisher Scientific Inc (NYSE: TMO) announced a deal to acquire the company for about $3.1 billion,  
Via Benzinga
$1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Looking Into Thermo Fisher Scientific's Recent Short Interest
Via Benzinga
Looking Into Thermo Fisher Scientific's Recent Short Interest
Via Benzinga
Looking Into Thermo Fisher Scientific's Recent Short Interest
Via Benzinga
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Via Benzinga
Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns
These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector. 
Via InvestorPlace
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
These defensive index funds can help investors hedge against a possible recession. 
Via The Motley Fool
Expert Ratings for Thermo Fisher Scientific
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China
KeyBanc Capital Markets analyst Paul Knight reiterated the Overweight rating on Danaher Corporation (NYSE: DHR),  
Via Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 5 Years
Via Benzinga
Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game
Robotics will upend laboratory research just as they upended factories. Bet on the future with these 3 robo-lab company stocks. 
Via InvestorPlace
7 Stocks Hedge Funds Are Loading Up On
Hedge funds and many other financial institutions are loading up on these names considered to be among top institutional stock picks. 
Via InvestorPlace
Danaher's Strategic Abcam Deal Boosts Growth at a Reasonable Price: Analyst
Monday, Danaher Corporation (NYSE: DHR) had agreed to acquire Abcam plc (NASDAQ: ABCM) for $24.00 per share in cash, or a total enterprise value of ~$5.7 billion, including assumed indebtedness  
Via Benzinga
$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.